| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |